Skip to content
Recall Observatory FDA recall evidence

Drug product

Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93

D-1171-2023

August 02, 2023

Class II

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 92948
Status
Terminated
Classification
Class II
Quantity
9,890 bottles
Official record key
drug-enforcement:D-1171-2023

Official wording

Reason: Failed dissolution specifications - results obtained were below spec average.

Code information: Lot #: 3112444, Exp 8/2023

Distribution pattern: USA nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed dissolution specifications